What is the ERA test?
- The Endometrial Receptivity Analysis (ERA), developed and patented by Igenomix (PCT/ ES2009/000386), is a test designed to evaluate endometrial receptivity.
- ERA® is the first diagnostic test that determines each woman’s unique personalized embryo transfer timing, therefore synchronizing the embryo transfer with the individualized window of implantation.
What is the procedure?
- The ERA utilizes RNA obtained from an endometrial tissue sample.The RNAanalyzed and then classified by our ERA predictor as receptive or non-receptive, depending on the expression profile of the RNA.
- If the endometrium is non-receptive, the test enables us to find a personalized window of implantation for each patient in the majority of cases.